Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) EBIT Margin (2020 - 2025)

Historic EBIT Margin for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to 9.51%.

  • NeuroPace's EBIT Margin rose 106400.0% to 9.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.21%, marking a year-over-year increase of 109600.0%. This contributed to the annual value of 27.12% for FY2024, which is 144200.0% up from last year.
  • As of Q3 2025, NeuroPace's EBIT Margin stood at 9.51%, which was up 106400.0% from 29.01% recorded in Q2 2025.
  • Over the past 5 years, NeuroPace's EBIT Margin peaked at 9.51% during Q3 2025, and registered a low of 107.59% during Q2 2022.
  • Its 5-year average for EBIT Margin is 48.27%, with a median of 36.46% in 2021.
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by -711300bps in 2022, then soared by 600200bps in 2023.
  • Quarter analysis of 5 years shows NeuroPace's EBIT Margin stood at 81.98% in 2021, then increased by 6bps to 77.09% in 2022, then soared by 64bps to 28.04% in 2023, then surged by 39bps to 17.02% in 2024, then soared by 44bps to 9.51% in 2025.
  • Its EBIT Margin stands at 9.51% for Q3 2025, versus 29.01% for Q2 2025 and 22.85% for Q1 2025.